📦 Box / Label 🔬 Composition 📋 Batch Info

VARILRIX · GSK · 0.5 mL after Reconstitution · Subcutaneous Injection · 2-Dose Schedule

Active ingredients per 0.5 mL dose · MRP ₹2,878 incl. taxes · GSK manufacturer label verified by VacciHub

Batch number, expiry & storage instructions · GSK manufacturer label

VARILRIX – Varicella (Chickenpox) Vaccine by GSK

VARILRIX is a live attenuated varicella (chickenpox) vaccine based on the well-studied Oka strain, manufactured by GSK. After reconstitution with the supplied diluent, a single 0.5 mL dose is given subcutaneously. A complete 2-dose schedule provides strong, long-lasting protection against chickenpox and significantly reduces the risk of moderate-to-severe disease, complications and household transmission. It is recommended for children, adolescents and adults who have not had chickenpox or a prior varicella vaccine.

🛡️ Who Should Get VARILRIX?

• Children (9 months+) – IAP recommends the first dose from 15 months of age
• Adolescents & Adults – Without a documented history of chickenpox or prior vaccination
• Women planning pregnancy – Complete vaccination at least 1 month before conception (not to be given during pregnancy)
• Healthcare workers, teachers & caregivers – Reduce occupational and household exposure risk

💉 VARILRIX Composition (Per 0.5 mL Reconstituted Dose)

Figures are as per the GSK manufacturer package insert available at the time of publishing. Please refer to the current package insert / consult your physician for the latest information.

📅 Dose Schedule

• Children under 13 years: 2 doses, minimum 3 months apart (IAP schedule: Dose 1 at 15 months, Dose 2 at 4–6 years)
• Individuals 13 years & older (including adults): 2 doses, 6–10 weeks apart (minimum gap 4 weeks)
• Catch-up vaccination: Can be given at any age to unvaccinated children/adults without prior evidence of immunity

🏥 Why Book VARILRIX with VacciHub?

⚠️ Side Effects

VARILRIX is generally well tolerated. Common mild effects include injection-site pain, redness, swelling and mild fever. Occasionally, a few chickenpox-like spots may appear at the injection site or elsewhere within 2–4 weeks – this is usually mild and self-limiting. Serious reactions are rare.

🚫 Precautions

• Not to be given during pregnancy; avoid conception for 1 month after vaccination
• Avoid in individuals with severe immunodeficiency or active untreated tuberculosis
• Avoid if there is a known allergy to neomycin
• Defer vaccination during high fever or acute illness
• Avoid aspirin/salicylate use for 6 weeks after vaccination, as a general precaution with varicella vaccination